Akero Therapeutics, Inc. (AKRO) Income Statement 2017 - 2025

Akero Therapeutics, Inc.

NasdaqGS:AKRO

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 4.26 B

Share Price

USD 51.41

Avg Daily Volume

1,443,244

Change (1 day)

-3.65%

Change (1 year)

121.98%

Change (YTD)

84.80%

Akero Therapeutics, Inc. Income Statement 2017 - 2025

This table shows the Income Statement for Akero Therapeutics, Inc. going from 2017 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.